11:45 AM - 12:45 PM
Late-Breaking Clinical Trials and Science: Clinical Trials Updates and Registries
- A Multielectrode Spherical Array Pulsed Field Ablation System to Treat Paroxysmal Atrial Fibrillation: 1-Year Outcomes of the PULSAR IDE Trial
- Safety, Efficacy and PVI Durability of a Contact Force-Sensing Large-Tip Focal Pulsed Field Ablation Catheter Integrated With 3D Mapping to Treat Paroxysmal Atrial Fibrillation: First-in-Human Omny-IRE 3-Month Results
- Left Bundle Branch Area Pacing Compared To Biventricular Pacing in Candidates for Cardiac Resynchronization Therapy (LVEF)
- Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Atrial Fibrillation Ablation: Lessons from The OPTION Trial
2:15 PM - 3:15 PM
Late-Breaking Clinical Trials and Science: Clinical Trials Updates and Registries
- More Major and Lead Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN XL Trial
- Evolution and Emergence of Diagnosis and Long-Term Outcome of Apparently Unexplained Cardiac Arrest
- Left bundle branch area placement of a novel small-diameter defibrillation lead: defibrillation results of the LEADR LBBAP clinical trial
- TRANSFORM-AF:Targeting Metabolic Therapy with GLP-1 Receptor Agonism for Secondary Prevention in Atrial Fibrillation
